Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / HighVista Strategies LLC
Form 13F · Q2 2026

HighVista Strategies LLC

CIK 1335325申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$4.4亿
申報組合市值
147
持倉數量
12
Quarters on record
Top 50
持倉數量

HighVista Strategies LLC——持倉

共 147 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1IVZ Invesco Db Commdy Indx Trck1.1M+0.0%$2819万6.4%
2ABVX Abivax Sa113,031−0.2%$1506万3.4%
3RVMD Revolution Medicines Inc66,983−3.4%$1254万2.9%
4DFTX Definium Therapeutics Inc242,884+30.7%$1143万2.6%
5IMVT Immunovant Inc277,873+23.4%$1071万2.4%
6PRAX Praxis Precision Medicines I30,210+14.8%$1011万2.3%
7RLAY Relay Therapeutics Inc506,235+20.0%$947万2.2%
8ALKS Alkermes Plc179,256+144.9%$939万2.1%
9PCVX Vaxcyte Inc149,739+20.1%$870万2.0%
10TNGX Tango Therapeutics Inc260,070+149.6%$813万1.9%
11LQDA Liquidia Corporation97,896−1.9%$781万1.8%
12COGT Cogent Biosciences Inc188,780−4.2%$731万1.7%
13GPCR Structure Therapeutics Inc130,784+5.5%$702万1.6%
14ELVN Enliven Therapeutics Inc137,866+88.6%$700万1.6%
15AMLX Amylyx Pharmaceuticals Inc386,080+9.7%$693万1.6%
16SYRE Spyre Therapeutics Inc77,807−46.8%$691万1.6%
17LBRX Lb Pharmaceuticals Inc211,511+21.8%$686万1.6%
18CYTK Cytokinetics Inc78,003+33.0%$665万1.5%
19CCCC C4 Therapeutics Inc1.3M—$630万1.4%
20TYRA Tyra Biosciences Inc184,774+40.7%$590万1.3%
21ALMS Alumis Inc199,968+77.1%$563万1.3%
22PHVS Pharvaris N V160,494+64.0%$555万1.3%
23TARS Tarsus Pharmaceuticals Inc87,060+65.9%$548万1.2%
24CMPS Compass Pathways Plc371,120+1.9%$525万1.2%
25DNTH Dianthus Therapeutics Inc51,125+43.7%$498万1.1%
26NRIX Nurix Therapeutics Inc203,739−10.1%$494万1.1%
27AXSM Axsome Therapeutics Inc.20,183−1.2%$494万1.1%
28TVTX Travere Therapeutics Inc86,233+137.4%$490万1.1%
29VERA Vera Therapeutics Inc105,907+53.0%$454万1.0%
30NVDA Nvidia Corporation21,792−2.8%$436万1.0%
31GHRS Gh Research Plc158,770−25.5%$427万1.0%
32PALI Palisade Bio Inc2.0M+0.6%$424万1.0%
33ARGX Argenx Se4,561−7.3%$423万1.0%
34MAZE Maze Therapeutics Inc136,572+36.8%$408万0.9%
35OCUL Ocular Therapeutix Inc408,534−7.5%$401万0.9%
36ORKA Oruka Therapeutics Inc41,902−46.9%$399万0.9%
37DYN Dyne Therapeutics Inc171,961−6.0%$382万0.9%
38EWTX Edgewise Therapeutics Inc90,996−1.0%$370万0.8%
39MLTX Moonlake Immunotherapeutics187,946−3.1%$366万0.8%
40INSM Insmed Inc31,256+28.5%$333万0.8%
41CLDX Celldex Therapeutics Inc New86,964−2.7%$324万0.7%
42AMZN Amazon Com Inc13,397−40.2%$319万0.7%
43IVA Inventiva Sa831,442+35.0%$314万0.7%
44TLN Talen Energy Corp8,148+161.3%$313万0.7%
45RLMD Relmada Therapeutics Inc445,799—$308万0.7%
46PTGX Protagonist Therapeutics Inc24,460−27.7%$300万0.7%
47ERAS Erasca Inc160,328−11.5%$294万0.7%
48VRDN Viridian Therapeutics Inc159,885+19.1%$294万0.7%
49HPE Hewlett Packard Enterprise C59,081−34.3%$267万0.6%
50MLYS Mineralys Therapeutics Inc86,085+84.0%$232万0.5%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。